Comment
Email
Print
Please log in to read this article:
Don't have a login yet?
Discover your benefits and register for free now! It only takes a minute.
|
|
|
Please log in to read this article:
Don't have a login yet?
Discover your benefits and register for free now! It only takes a minute.
Most viewed in Health & society
EU takes over biocides approval from member statesAuthorisation regime will now be handled by the European Chemicals Agency. |
'Inconclusive' data about breast implant risksCommission report says more information needed on health risks from implants made by French firm. |
 |
Call for safety controls in wake of implant scareEuropean commissioner for health tells member states to ensure safety of medical devices. |
 |
John Bowis MEP, British Conservative (EPP-ED) MEP, drafting report on the proposed directive on patients' rights to cross-border healthcare;
Alastair Kent, director of the Genetic Interest Group (GIG);
Dr Ad R Schuurman, Head of Reimbursement Department at Dutch health care insurance board (CVZ), Chair of the Medicine Evaluation Committee (MEDEV);
Professor Finn Børlum Kristensen, project leader at the European Network for Health Technology Assessment (EUnetHTA), and director of the Danish agency for Health Technology Assessment (DACEHTA), National Board of Health;
Chaired by Dr Phil Hammond, UK-based general practitioner and journalist.
Additional details about the debate are available here.
Fill in our feedback form by clicking here.
Related articles
European commissioner for health tells member states to ensure safety of medical devices.
Commission report says more information needed on health risks from implants made by French firm.
Authorisation regime will now be handled by the European Chemicals Agency.
Different reactions from member states to health scare.
Cadmium was added to banned list as part of the REACH chemicals legislation last year.
